Clinical outcomes and improved survival in patients with protein-losing enteropathy after the fontan operation

Journal of the American College of Cardiology

Volumn 64, Issue 1, 2014, Pages 54-62

  John, Anitha S ^a,b,d   Johnson, Jennifer A ^b,c   Khan, Munziba ^a   Driscoll, David J ^b   Warnes, Carole A ^b   Cetta, Frank ^b  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b MAYO CLINIC   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

Fontan procedure; protein losing enteropathy

Indexed keywords

OCTREOTIDE; SILDENAFIL; SPIRONOLACTONE;

ADULT; ARTICLE; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FENESTRATION; FONTAN PROCEDURE; HEART ATRIUM ARRHYTHMIA; HEART EJECTION FRACTION; HEART INDEX; HUMAN; LUNG VASCULAR RESISTANCE; MALE; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; OXYGEN SATURATION; PRIORITY JOURNAL; PROTEIN LOSING GASTROENTEROPATHY; RETROSPECTIVE STUDY; SURGICAL MORTALITY; SURGICAL RISK; SURVIVAL RATE; SURVIVAL TIME;

FONTAN PROCEDURE; PROTEIN-LOSING ENTEROPATHY;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FONTAN PROCEDURE; HUMANS; INFANT; MALE; MIDDLE AGED; PROTEIN-LOSING ENTEROPATHIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84903839849     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.04.025     Document Type: Article

References (25)

1. L. Mertens, D.J. Hagler, and U. Sauer et al. Protein-losing enteropathy after the Fontan operation: an international multicenter study. PLE Study Group J Thorac Cardiovasc Surg 115 1998 1063 1073
2. R.H. Feldt, D.J. Driscoll, and K.P. Offord et al. Protein-losing enteropathy after the Fontan operation J Thorac Cardiovasc Surg 112 1996 672 680
3. D. Thacker, A. Patel, and K. Dodds et al. Use of oral budesonide in the management of protein-losing enteropathy after the Fontan operation Ann Thorac Surg 89 2010 837 842
4. Z. Reinhardt, O. Uzun, and V. Bhole et al. Sildenafil in the management of the failing Fontan circulation Cardiol Young 20 2010 522 525
5. L. Mertens, M. Dumoulin, and M. Gewillig Effect of percutaneous fenestration of the atrial septum on protein-losing enteropathy after the Fontan operation Br Heart J 72 1994 591 592
6. A.M. Sheikh, A.T. Tang, and K. Roman et al. The failing Fontan circulation: successful conversion of atriopulmonary connections J Thorac Cardiovasc Surg 128 2004 60 66
7. J. Meadows, and K. Jenkins Protein-losing enteropathy: integrating a new disease paradigm into recommendations for prevention and treatment Cardiol Young 21 2011 363 377
8. D.J. Driscoll, K.P. Offord, and R.H. Feldt et al. Five- to fifteen-year follow-up after Fontan operation Circulation 85 1992 469 496
9. C. Stamm, I. Friehs, and J.E. Mayer Jr. et al. Long-term results of the lateral tunnel Fontan operation J Thorac Cardiovasc Surg 121 2001 28 41
10. J. Rychik, and S. Gui-Yang Relation of mesenteric vascular resistance after Fontan operation and protein-losing enteropathy Am J Cardiol 90 2002 672 674
11. J.A. Johnson, F. Cetta, and R.P. Graham et al. Identifying predictors of hepatic disease in patients after the Fontan operation: a postmortem analysis J Thorac Cardiovasc Surg 146 2013 140 145
12. A.S. John, D.J. Driscoll, and C.A. Warnes et al. The use of oral budesonide in adolescents and adults with protein-losing enteropathy after the Fontan operation Ann Thorac Surg 92 2011 1451 1456
13. A.M. Kelly, R.H. Feldt, and D.J. Driscoll et al. Use of heparin in the treatment of protein-losing enteropathy after Fontan operation for complex congenital heart disease Mayo Clin Proc 73 1998 777 779
14. J.N. Johnson, D.J. Driscoll, and P.W. O'Leary Protein-losing enteropathy and the Fontan operation Nutr Clin Pract 27 2012 375 384
15. S. Menon, D. Hagler, and F. Cetta et al. Role of caval venous manipulation in treatment of protein-losing enteropathy Cardiol Young 18 2008 275 281
16. J. Rychik, J.J. Rome, and M.L. Jacobs Late surgical fenestration for complications after the Fontan operation Circulation 96 1997 33 36
17. C. Mavroudis, B.J. Deal, and C.L. Backer et al. J. 111 Fontan conversions with arrhythmia surgery: surgical lessons and outcomes Ann Thorac Surg 84 2007 1457 1465
18. S.C. Menon, J.A. Dearani, and F. Cetta Long-term outcome after atrioventricular valve surgery following modified Fontan operation Cardiol Young 21 2011 83 88
19. D.J. Goldberg, B. French, and A.L. Szwast et al. Impact of sildenafil on echocardiographic indices of myocardial performance after the Fontan operation Pediatr Cardiol 33 2012 689 696
20. D.J. Goldberg, B. French, and M.G. McBride et al. Impact of oral sildenafil on exercise performance in children and young adults after the Fontan operation: a randomized, double-blind, placebo-controlled, crossover trial Circulation 123 2011 1185 1193
21. J. Rhodes, A. Ubeda-Tikkanen, and M. Clair et al. Effect of inhaled iloprost on the exercise function of Fontan patients: a demonstration of concept Int J Cardiol 168 2013 2435 2440
22. R.E. Ringel, and S.B. Peddy Effect of high-dose spironolactone on protein-losing enteropathy in patients with Fontan palliation of complex congenital heart disease Am J Cardiol 91 2003 1031 1032
23. J.M. Elinoff, J.E. Rame, and P.R. Forfia et al. A pilot study of the effect of spironolactone therapy on exercise capacity and endothelial dysfunction in pulmonary arterial hypertension: study protocol for a randomized controlled trial Trials 14 2013 91
24. B.A. Maron, A.R. Opotowsky, and M.J. Landzberg et al. Plasma aldosterone levels are elevated in patients with pulmonary arterial hypertension in the absence of left ventricular heart failure: a pilot study Eur J Heart Fail 15 2013 277 283
25. A.S. John, S.D. Phillips, and D.J. Driscoll et al. The use of octreotide to successfully treat protein-losing enteropathy following the Fontan operation Congenit Heart Dis 6 2011 653 656